United Asset Strategies’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,564
| Closed | -$1.68M | – | 248 |
|
|
2024
Q3 | $1.68M | Buy |
15,564
+387
| +3% | +$41.8K | 0.16% | 117 |
|
|
2024
Q2 | $1.65M | Buy |
15,177
+788
| +5% | +$85.5K | 0.16% | 111 |
|
|
2024
Q1 | $1.9M | Buy |
14,389
+591
| +4% | +$78K | 0.19% | 100 |
|
|
2023
Q4 | $1.68M | Sell |
13,798
-2,754
| -17% | -$335K | 0.19% | 100 |
|
|
2023
Q3 | $1.86M | Sell |
16,552
-691
| -4% | -$77.5K | 0.24% | 88 |
|
|
2023
Q2 | $2.51M | Sell |
17,243
-69
| -0.4% | -$10K | 0.31% | 71 |
|
|
2023
Q1 | $2.24M | Buy |
17,312
+618
| +4% | +$79.8K | 0.3% | 74 |
|
|
2022
Q4 | $2.13M | Buy |
16,694
+747
| +5% | +$95.2K | 0.3% | 76 |
|
|
2022
Q3 | $1.67M | Buy |
15,947
+189
| +1% | +$19.8K | 0.26% | 86 |
|
|
2022
Q2 | $1.66M | Buy |
15,758
+332
| +2% | +$34.9K | 0.24% | 83 |
|
|
2022
Q1 | $1.97M | Buy |
15,426
+1,048
| +7% | +$134K | 0.25% | 78 |
|
|
2021
Q4 | $1.77M | Buy |
14,378
+832
| +6% | +$103K | 0.21% | 86 |
|
|
2021
Q3 | $1.93M | Buy |
13,546
+772
| +6% | +$110K | 0.25% | 76 |
|
|
2021
Q2 | $1.99M | Buy |
12,774
+626
| +5% | +$97.7K | 0.27% | 70 |
|
|
2021
Q1 | $1.89M | Buy |
12,148
+1,407
| +13% | +$219K | 0.27% | 73 |
|
|
2020
Q4 | $1.61M | Buy |
10,741
+62
| +0.6% | +$9.28K | 0.25% | 78 |
|
|
2020
Q3 | $1.41M | Sell |
10,679
-629
| -6% | -$83.1K | 0.26% | 76 |
|
|
2020
Q2 | $1.31M | Sell |
11,308
-184
| -2% | -$21.3K | 0.26% | 79 |
|
|
2020
Q1 | $1.13M | Buy |
11,492
+684
| +6% | +$67.1K | 0.28% | 77 |
|
|
2019
Q4 | $1.57M | Buy |
+10,808
| New | +$1.57M | 0.31% | 81 |
|